The cytotoxicity of continuous ambulatory peritoneal dialysis solutions with different bicarbonate/lactate ratios
- PMID: 8399544
The cytotoxicity of continuous ambulatory peritoneal dialysis solutions with different bicarbonate/lactate ratios
Abstract
Five different bicarbonate-based continuous ambulatory peritoneal dialysis (CAPD) solutions (pH: 7.0-7.4; bicarbonate: 10-27 mM; lactate: 20.8-6.7 mM) were produced in order to examine the cytotoxic effects of the different compositions. The migratory capacity of normal human polymorphonuclear (PMN) granulocytes after exposure to the solutions was used as a cytotoxicity assay. All the tested solutions reduced cellular function compared to a standard cell culture medium, but considerable differences between the solutions were observed. The optimal conditions for the PMN migration were at a pH of 7.0 and at bicarbonate and lactate concentrations of 20 mM and 12.5 mM, respectively. Bicarbonate concentrations of more than 25 mM were associated with reduced cellular function as were lactate concentrations of more than 15 mM. The most advantageous CAPD solution regarding cytotoxicity towards normal human PMN's is a combination of a lactate and bicarbonate-based solution, which has a bicarbonate concentration of approximately 20 mM, a lactate concentration of 12.5 mM, and a pH of approximately 7.2.
Similar articles
-
Bicarbonate is not the ultimate answer to the biocompatibility problems of CAPD solutions: a cytotoxicity test of CAPD solutions and effluents.Adv Perit Dial. 1992;8:42-6. Adv Perit Dial. 1992. PMID: 1361838
-
Osmotic agents and buffers in peritoneal dialysis solution: monocyte cytokine release and in vitro cytotoxicity.Am J Kidney Dis. 1997 Sep;30(3):413-22. doi: 10.1016/s0272-6386(97)90287-0. Am J Kidney Dis. 1997. PMID: 9292571
-
Biocompatibility of bicarbonate buffered peritoneal dialysis fluids: influence on mesothelial cell and neutrophil function.Kidney Int. 1996 May;49(5):1447-56. doi: 10.1038/ki.1996.204. Kidney Int. 1996. PMID: 8731113
-
Effect of different buffers on the biocompatibility of CAPD solutions.Perit Dial Int. 1996;16 Suppl 1:S130-6. Perit Dial Int. 1996. PMID: 8728179 Review.
-
Lactate-versus bicarbonate-based peritoneal dialysis solutions.Perit Dial Int. 1995;15(7 Suppl):S47-50; discussion S51. Perit Dial Int. 1995. PMID: 8555326 Review. No abstract available.
Cited by
-
Conventional versus biocompatible peritoneal dialysis fluids: more questions than answers?NDT Plus. 2008 Oct;1(Suppl 4):iv46-iv50. doi: 10.1093/ndtplus/sfn124. NDT Plus. 2008. PMID: 25983986 Free PMC article.
-
A new peritoneal dialysis fluid for Japanese patients: a randomized non-inferiority clinical trial of safety and efficacy.Clin Exp Nephrol. 2017 Oct;21(5):895-907. doi: 10.1007/s10157-016-1346-9. Epub 2016 Oct 25. Clin Exp Nephrol. 2017. PMID: 27783275 Free PMC article. Clinical Trial.
-
Biocompatibility of a new PD solution for Japan, Reguneal™, measured as in vitro proliferation of fibroblasts.Clin Exp Nephrol. 2018 Dec;22(6):1427-1436. doi: 10.1007/s10157-018-1602-2. Epub 2018 Jun 20. Clin Exp Nephrol. 2018. PMID: 29926312
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources